Detalles de la búsqueda
1.
[CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS].
Arerugi;
72(10): 1230-1239, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-38092399
2.
[CLINICAL EFFICASY OF HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY WITH MITICURE® TABLETS IN 115 PAITENTS FOR 3 YEARS].
Arerugi;
72(3): 273-280, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-37225468
3.
[ENHANCED CLINICAL EFFECTS OF CEDARCURE® TABLETS OF SUBLINGUAL IMMUNOTHERAPY OVER THE YEARS OF TREATMENT AND THE IMPACT OF OUTCOME BY COMBINED USE OF MITE SUBLINGUAL IMMUNOTHERAPY (DUAL SLIT) FOR JAPANESE CEDAR POLLINOSIS].
Arerugi;
71(9): 1122-1128, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-36372423
4.
[COMPARISON OF CLINICAL EFFICACY AND SAFETY BETWEEN CHILDREN AND ADULTS BEFORE AND 1 YEAR AFTER MITE SUBLINGUAL IMMUNOTHERAPY FOR PERENNIAL ALLERGIC RHINITIS].
Arerugi;
70(3): 186-194, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-34011773
5.
[EFFICACY AND SAFETY OF PEDIATRIC SUBLINGUAL IMMMUNOTHERAPY WITH CEDARCURE® IN CLINICAL PRACTICE FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP SEASON].
Arerugi;
69(9): 909-917, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-33191379
6.
[CLINICAL EFFICACY OF 69 PATIENTS WITH JAPANESE CEDAR POLLINOSIS TREATED BY SUBLINGUAL IMMUNOTHERAPY WITH CEDARCURE® IN THE FIRST FOLLOW-UP YEAR].
Arerugi;
68(8): 958-965, 2019.
Artículo
en Japonés
| MEDLINE | ID: mdl-31534107
7.
[CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN A LARGE AMOUNT OF POLLEN DISPARSAL AND IT'S IMPACT OF TREATMENT YEAR].
Arerugi;
67(8): 1011-1019, 2018.
Artículo
en Japonés
| MEDLINE | ID: mdl-30249950
8.
[CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
Arerugi;
66(9): 1172-1180, 2017.
Artículo
en Japonés
| MEDLINE | ID: mdl-29129888
9.
Enhanced Clinical Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis in the Second Year of Treatment.
Nihon Jibiinkoka Gakkai Kaiho;
120(1): 44-51, 2017 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-30035467
10.
CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE SECOND TREATED YEAR FOR 133 PATIENTS WITH JAPANESE CEDAR POLLINOSIS IN 2016.
Arerugi;
65(9): 1209-1218, 2016.
Artículo
en Japonés
| MEDLINE | ID: mdl-27885205
11.
Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar Pollinosis.
Nihon Jibiinkoka Gakkai Kaiho;
119(12): 1504-10, 2016 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-30035481
12.
[CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP YEAR].
Arerugi;
64(10): 1323-33, 2015 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-26727137
13.
[Adverse Events of Sublingual Immunotherapy in 207 Patients with Japanese Cedar Pollinosis].
Nihon Jibiinkoka Gakkai Kaiho;
118(12): 1429-35, 2015 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-26964395
14.
IL-33-activated dendritic cells induce an atypical TH2-type response.
J Allergy Clin Immunol;
123(5): 1047-54, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19361843
Resultados
1 -
14
de 14
1
Próxima >
>>